Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2000-10-11
pubmed:abstractText
Inhibition of skeletal mineralisation is a well-recognized complication of disodium etidronate therapy that was identified in the earliest studies of its use in osteoporosis and Paget's disease. The effect is seen at lower doses in Paget's disease than in osteoporosis. Several cases of spontaneous fractures occurring in unaffected bones of Paget's patients have been reported. However, we believe the case described here is the most severe example of etidronate-induced osteomalacia published in the literature, featuring widespread vertebral collapse occurring as a consequence of nearly 10 years of uninterrupted etidronate treatment for isolated hemipelvic Paget's disease.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0364-2348
pubmed:author
pubmed:issnType
Print
pubmed:volume
29
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
279-82
pubmed:dateRevised
2006-3-8
pubmed:meshHeading
pubmed-meshheading:10883448-Aged, pubmed-meshheading:10883448-Alkaline Phosphatase, pubmed-meshheading:10883448-Anti-Inflammatory Agents, pubmed-meshheading:10883448-Arthralgia, pubmed-meshheading:10883448-Diphosphonates, pubmed-meshheading:10883448-Etidronic Acid, pubmed-meshheading:10883448-Follow-Up Studies, pubmed-meshheading:10883448-Fractures, Spontaneous, pubmed-meshheading:10883448-Humans, pubmed-meshheading:10883448-Kyphosis, pubmed-meshheading:10883448-Lumbar Vertebrae, pubmed-meshheading:10883448-Male, pubmed-meshheading:10883448-Osteitis Deformans, pubmed-meshheading:10883448-Osteomalacia, pubmed-meshheading:10883448-Osteoporosis, pubmed-meshheading:10883448-Pelvic Bones, pubmed-meshheading:10883448-Spinal Diseases, pubmed-meshheading:10883448-Spinal Fractures, pubmed-meshheading:10883448-Thoracic Vertebrae
pubmed:year
2000
pubmed:articleTitle
Gross vertebral collapse associated with long-term disodium etidronate treatment for pelvic Paget's disease.
pubmed:affiliation
Division of Bone and Mineral Metabolism, Royal National Orthopaedic Hospital, Stanmore, Middlesex, UK.
pubmed:publicationType
Journal Article, Case Reports